MBX Biosciences (MBX) Institutional Ownership $17.61 -1.88 (-9.65%) (As of 04:25 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for MBX Biosciences (NYSE:MBX)Number ofInstitutional Buyers(last 12 months)10TotalInstitutional Inflows(last 12 months)$214.77MNumber ofInstitutional Sellers(last 12 months)0 Get MBX Insider Trade Alerts Want to know when executives and insiders are buying or selling MBX Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data MBX Institutional Buying and Selling by Quarter Ad Crypto 101 MediaThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech giants are quietly integrating it. Venture capitalists are scrambling to invest.Click here to discover our #1 crypto for the market right now – poised for massive growth MBX Biosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2024Jane Street Group LLC26,570$690K0.0%N/A0.080% 11/15/2024Wellington Management Group LLP2,937,853$74.26M0.0%N/A8.791% 11/15/2024Soros Fund Management LLC30,000$779K0.0%N/A0.090% 11/15/2024RA Capital Management L.P.1,511,334$39.26M0.5%N/A4.522% 11/15/2024Point72 DIFC Ltd24,011$624K0.0%N/A0.072% 11/15/2024Point72 Asset Management L.P.15,600$405K0.0%N/A0.047% 11/15/2024Maven Securities LTD50,000$1.30M0.0%N/A0.150% 11/15/2024Point72 Asia Singapore Pte. Ltd.10,706$278K0.1%N/A0.032% 11/14/2024NEA Management Company LLC3,614,486$93.90M5.1%N/A10.816% 11/13/2024 The Manufacturers Life Insurance Company 46,194$1.20M0.0%N/A0.138% (Data available from 1/1/2016 forward) MBX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MBX shares? During the previous two years, 10 institutional investors and hedge funds held shares of MBX Biosciences. The most heavily invested institutionals were NEA Management Company LLC ($93.90M), Wellington Management Group LLP ($74.26M), RA Capital Management L.P. ($39.26M), Maven Securities LTD ($1.30M), The Manufacturers Life Insurance Company ($1.20M), Soros Fund Management LLC ($779K), and Jane Street Group LLC ($690K).Learn more on MBX's institutional investors. Which institutional investors have been buying MBX Biosciences stock? Of the 10 institutional investors that purchased MBX Biosciences stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: NEA Management Company LLC ($3.61M), Wellington Management Group LLP ($2.94M), RA Capital Management L.P. ($1.51M), Maven Securities LTD ($50K), The Manufacturers Life Insurance Company ($46.19K), Soros Fund Management LLC ($30K), and Jane Street Group LLC ($26.57K). How much institutional buying is happening at MBX Biosciences? Institutional investors have bought a total of 8,266,754 shares in the last 24 months. This purchase volume represents approximately $214.77M in transactions. Related Companies ACADIA Pharmaceuticals Institutional Ownership MorphoSys Institutional Ownership Amneal Pharmaceuticals Institutional Ownership Dyne Therapeutics Institutional Ownership Janux Therapeutics Institutional Ownership Catalyst Pharmaceuticals Institutional Ownership IDEAYA Biosciences Institutional Ownership Protagonist Therapeutics Institutional Ownership Arrowhead Pharmaceuticals Institutional Ownership Vera Therapeutics Institutional Ownership This page (NYSE:MBX) was last updated on 11/15/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredNvidia’s world of pain awaitsThe Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MBX Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MBX Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.